Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Leveraging zeta potential as a surface charge metric for trapping and killing of airborne bacteria
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 10 February 2026

Leveraging zeta potential as a surface charge metric for trapping and killing of airborne bacteria

  • Arun Sai Kumar Peketi1 na1,
  • Sai Kushal Kumar SVL1 na1,
  • Kennedy Kumar P2,
  • Jayaprada Rangineni3,
  • Balaji Veeraraghavan4 &
  • …
  • Eswarappa Pradeep Bulagonda1 

Scientific Reports , Article number:  (2026) Cite this article

  • 707 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Applied microbiology
  • Bacterial infection

Abstract

Airborne microorganisms significantly contribute to hospital-associated infections (HAIs), particularly causing respiratory tract infections (RTIs). The spread of Multi-Drug Resistant (MDR) airborne bacteria further complicates disease prevention, challenging existing infection control strategies. Current air decontamination technologies are found to have limitations, necessitating novel approaches. In this study, we demonstrated the utility of zeta potential, a natural physicochemical electro-kinetic property of bacteria as a key target, which can be exploited to trap and eliminate MDR airborne bacteria. Multiple respiratory pathogens were included in the study, harbouring various resistance phenotypes. Zeta potentials of these clinical isolates were measured and compared against corresponding ATCC strains. Clinical isolates were aerosolized in a certified BSL-2 setting containing a ZeBox-powered air sterilization device. Viable bacteria were enumerated at various time points, before and after exposure to the air decontamination device. Our analyses revealed that Zeta potential is relatively independent of the origin and antibiotic susceptibility of the tested isolates. Exposure to ZeBox powered device for 5 min resulted in a minimum of 5 log reduction (99.999%) among majority of the isolates, irrespective of their genus and origin. Zeta potential measurements correlated to the kill kinetics of ZeBox technology. The current study underscores the reliability of zeta potential based air decontamination technologies such as ZeBox for potential elimination of diverse, airborne respiratory pathogens in healthcare and domestic settings, offering a promising strategy to combat HAIs in post antibiotic and post pandemic era.

Data availability

All data generated or analyzed during this study are included in this article.

References

  1. Ghimire, P., Gachhadar, R., Piya, N., Shrestha, K. & Shrestha, K. Prevalence and factors associated with acute respiratory infection among under-five children in selected tertiary hospitals of Kathmandu Valley. PLOS ONE. 17, e0265933. https://doi.org/10.1371/journal.pone.0265933 (2022).

    Google Scholar 

  2. Regha, I. & B, S. Bacteriological profile and antibiotic susceptibility patterns of lower respiratory tract infections in a tertiary care hospital, central Kerala. IP Int. J. Med. Microbiol. Trop. Dis. 4, 186–190 (2018).

    Google Scholar 

  3. Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0 (2022).

    Google Scholar 

  4. Eshwara, V. K., Mukhopadhyay, C. & Rello, J. Community-acquired bacterial pneumonia in adults: an update. Indian J. Med. Res. 151, 287–302. https://doi.org/10.4103/ijmr.IJMR_1678_19 (2020).

    Google Scholar 

  5. Dandona, L. et al. Nations within a nation: variations in epidemiological transition across the States of India, 1990–2016 in the global burden of disease study. Lancet 390, 2437–2460. https://doi.org/10.1016/S0140-6736(17)32804-0 (2017).

    Google Scholar 

  6. Sarmah, N., Sarmah, A. & Das, D. K. A study on the Microbiological profile of respiratory tract infection (RTI) in patients attending Gauhati medical college & hospital. Annals Int. Med. Dent. Res. 2, MB11–MB15 (2016).

    Google Scholar 

  7. Phadke, K. S. et al. Novel Non intrusive continuous use ZeBox technology to trap and kill airborne microbes. Sci. Rep. 11, 22779. https://doi.org/10.1038/s41598-021-02184-4 (2021).

    Google Scholar 

  8. Narayan, R., Kundu, D., Ghatak, A., Tripathi, S. & Datta, S. Efficient elimination of airborne pathogens: a study on aerosolized Mycobacterium tuberculosis and SARS-CoV-2 using ZeBox technology. J. Hosp. Infect. 129, 17–21. https://doi.org/10.1016/j.jhin.2022.07.021 (2022).

    Google Scholar 

  9. Soon, R. L. et al. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment. J. Antimicrob. Chemother. 66, 126–133. https://doi.org/10.1093/jac/dkq422 (2010).

    Google Scholar 

  10. Esposito, F. et al. Detection of Colistin-Resistant MCR-1-Positive Escherichia coli by use of assays based on Inhibition by EDTA and zeta potential. J. Clin. Microbiol. 55, 3454–3465. https://doi.org/10.1128/jcm.00835-17 (2017).

    Google Scholar 

  11. Lavoie, T., Daffinee, K. E., Vicent, M. L. & LaPlante, K. L. Staphylococcus biofilm dynamics and antibiotic resistance: insights into biofilm stages, zeta potential dynamics, and antibiotic susceptibility. Microbiol. Spectr. 13, e02915–02924. https://doi.org/10.1128/spectrum.02915-24 (2025).

    Google Scholar 

  12. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 34th Edition. Clinical and Laboratory Standards Institute USA. (2024).

  13. Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infection: Official Publication Eur. Soc. Clin. Microbiol. Infect. Dis. 18, 268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x (2012).

    Google Scholar 

  14. Nagaraj, S. et al. Effectiveness of a novel, non-intrusive, continuous-use air decontamination technology to reduce microbial contamination in clinical settings: a multi-centric study. J. Hosp. Infect. 123, 15–22. https://doi.org/10.1016/j.jhin.2022.02.002 (2022).

    Google Scholar 

Download references

Acknowledgements

The authors acknowledge Dr. Santanu Datta and Dr. Arindam Ghatak, Biomoneta Private Limited, Bangalore for providing access to the Zebox powered instrument; University Grants Commission, UGC-SAP-DRS-III, Department of Science and Technology, DST-FIST and Department of Biotechnology, DBT-BIF, Govt. of India for the infrastructural support to the Department of Biosciences, SSSIHL, Prasanthi Nilayam and Indian Council of Medical Research, ICMR-SRF from Govt. of India to ASKP. BEP received extramural Research support from ICMR, Govt. of India. (OMI/27/2020-ECD-I and AMR/Adhoc/281/2022-ECD-II).

Author information

Author notes
  1. Arun Sai Kumar Peketi and SVL Sai Kushal Kumar contributed equally to this work.

Authors and Affiliations

  1. Department of Biosciences, Sri Sathya Sai Institute of Higher Learning, Vidyagiri, Prasanthi Nilayam, Puttaparthi, 515134, Andhra Pradesh, India

    Arun Sai Kumar Peketi, Sai Kushal Kumar SVL & Eswarappa Pradeep Bulagonda

  2. Department of Microbiology, Sri Ramachandra Medical Center, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, 600116, Tamil Nadu, India

    Kennedy Kumar P

  3. Department of Microbiology, Sri Venkateswara Institute of Medical Sciences, Tirupati, India

    Jayaprada Rangineni

  4. Department of Clinical Microbiology, Christian Medical College, Vellore, India

    Balaji Veeraraghavan

Authors
  1. Arun Sai Kumar Peketi
    View author publications

    Search author on:PubMed Google Scholar

  2. Sai Kushal Kumar SVL
    View author publications

    Search author on:PubMed Google Scholar

  3. Kennedy Kumar P
    View author publications

    Search author on:PubMed Google Scholar

  4. Jayaprada Rangineni
    View author publications

    Search author on:PubMed Google Scholar

  5. Balaji Veeraraghavan
    View author publications

    Search author on:PubMed Google Scholar

  6. Eswarappa Pradeep Bulagonda
    View author publications

    Search author on:PubMed Google Scholar

Contributions

BEP designed the study, KKP provided the clinical isolates, ASKP and SVLSKK conducted the experiments and prepared the draft manuscript. *S. pneumoniae* , *H. influenzae* and ATCC strains were provided along with their AST reports by RJ and BV respectively. BEP reviewed and prepared the final version of the manuscript.

Corresponding author

Correspondence to Eswarappa Pradeep Bulagonda.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval and consent to participate

This study was conducted following approval from the Institutional Ethics Committee (IEC) of Sri Sathya Sai Institute of Higher Learning (SSSIHL/IEC/PSN/BS/2014/03) and Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai (IEC-NI/20/JAN/73/04) in accordance with the ethical standards of the Declaration of Helsinki. informed consent was obtained from all subjects and/or their legal guardian(s).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peketi, A.S.K., SVL, S., P, K.K. et al. Leveraging zeta potential as a surface charge metric for trapping and killing of airborne bacteria. Sci Rep (2026). https://doi.org/10.1038/s41598-026-38958-x

Download citation

  • Received: 04 June 2025

  • Accepted: 02 February 2026

  • Published: 10 February 2026

  • DOI: https://doi.org/10.1038/s41598-026-38958-x

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Respiratory tract infection
  • Multi-drug resistant
  • Zeta potential
  • Air sterilization
  • ESKAPE pathogens.
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology